Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | L. Siculella et al., Biochim. et Biophys. Acta, 2016, 1861: 471-481; doi.org/10.1016/j.bbalip.2016.02.003 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | O. Pellerito et al., Mol. Pharmacol., May 2010; 77: 854 - 863 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | miRNA | Metafectene PRO | publication | D.-W. Choi et al., Int. J. Mol. Med., 2021,48(6): 221, DOI: 10.3892/ijmm.2021.5054 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | T. H. Pham et al., J. Virol., Mar 2013; 87: 3076 - 3086 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | G. Brusotti et al., SCIENTIfIC REPORTS, nature.com, 7:5777, DOI:10.1038/s41598-017-05666-6 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | A. Seifert, Dissertation, 2007, Martin-Luther-Universität | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | miRNA | Metafectene PRO | publication | M. Vinod et al., Biochim. et Biophys. Acta, 2014, 1841: 827-835, doi.org/10.1016/j.bbalip.2014.02.006 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Wedeken et al., J. Biol. Chem., Dec 2011; 286: 42855 - 42862. | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | F. Damiano et al., Biochim. et Biophys. Acta, 2015, 1849: 23-31; doi.org/10.1016/j.bbagrm.2014.10.004 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | M.-H. Tai et al., Mol. Nutr. Food Res., 2014, 58: 2133-2145 DOI 10.1002/mnfr.201400366 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | R. Montanari et a., Scientific Reports, 2016, 6: 27658, DOI: 10.1038/srep27658 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | C. Maucksch et al., Nucleic Acids Res., Oct 2008; 36: 5462 - 5471 | Link | ||
HepG2.2.15 |
Human hepatoma cell line expressing complete HBV genome | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Zhu et al., Zhonghua Gan Zang Bing Za Zhi, Sep 2004; 12(9): 522-5 | |||
HepG2.2.15 |
Human hepatoma cell line expressing complete HBV genome | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Zhu et al., Zhonghua Yi Xue Za Zhi, Sep 2005; 85(35): 2503-6 | |||
hESC |
Human embryonic stem cells | Human | unknown | stem cell | adherent | plasmid | Metafectene PRO | publication | J. Suchánková et al., Europ. J. of Histochemistry, 2014; 58:2389, doi:10.4081/ejh.2014.2389 | Link | |||
hESC-RPE |
Human embryonic stem cell-derived retinal pigment epithelium cells | Human | sensory organs | primary cell | siRNA | RNA-Interference | Metafectene PRO | publication | E. Ramsay et al., Pharmaceutics, 2020, 12(7): 667, doi: 10.3390/pharmaceutics12070667 | Link | |||
HFF |
Human foreskin fibroblasts | Human | genital tract | primary cell | adherent | bacmid | K2 Transfection System | publication | K. L. Sampaio et al., Viruses, 2021, 13, 1094, doi.org/10.3390/v13061094 | Link | |||
HFF |
Human foreskin fibroblasts | Human | genital tract | primary cell | adherent | bacmid | virusproduction | K2 Transfection System | publication | K. Laib Sampaio et al., Journal of General Virology, 2016, 97: 1917-1927, DOI 10.1099/jgv.0.000475 | Link | ||
HFF |
Human foreskin fibroblasts | Human | genital tract | primary cell | adherent | bacmid | virusproduction | K2 Transfection System | publication | C. Stegmann et al., J. of Virology, 2019, 93: 11, e00138-19, doi.org/10.1128/JVI.00138-19 | Link | ||
HFFF-tet |
Human fetal foreskin fibroblasts (hTERT-immortalized expressing the tetracycline repressor) | Human | genital tract | cell line | adherent | bacmid | virusproduction | K2 Transfection System | publication | K. Laib Sampaio et al., Journal of General Virology, 2016, 97: 1917-1927, DOI 10.1099/jgv.0.000475 | Link | ||
HFFFtet |
Human fetal foreskin fibroblasts (hTERT-immortalized expressing the tetracycline repressor) | Human | genital tract | cell line | adherent | bacmid | K2 Transfection System | publication | N. Weiler et al., Viruses, 2021, 13: 614, doi.org/10.3390/v13040614 | Link |